NeuroSense Therapeutics (NRSN) EPS (2021 - 2025)
NeuroSense Therapeutics (NRSN) EPS from Dec 31, 2021 to Dec 31, 2025. The TTM NeuroSense Therapeutics (NRSN) EPS is -$0.34. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
NeuroSense Therapeutics (NRSN) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year | -22.29% |
| 3 Years | -27.34% |
| All Time | -9.79% |
Annual EPS change of NeuroSense Therapeutics (NRSN)
| Year | EPS | Change |
|---|---|---|
| 2025 | -$0.34 | -22.29% |
| 2024 | -$0.44 | -33.14% |
| 2023 | -$0.66 | -26.16% |
| 2022 | -$0.89 | +37.59% |
| 2021 | -$0.65 | N/A |
Comparison NeuroSense Therapeutics (NRSN) five years EPS CAGR with competitors
NeuroSense Therapeutics (NRSN) five years EPS CAGR is -17.43%.